
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (03): 335-342.DOI: 10.12114/j.issn.1007-9572.2022.0276
Special Issue: 老年问题最新文章合辑; 心力衰竭最新文章合辑; 心血管最新文章合辑; 营养最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2022-05-11
Revised:2022-07-21
Published:2023-01-20
Online:2022-09-01
Contact:
CHEN Ying
About author:
通讯作者:
陈莹
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0276
| 项目 | 无营养不良风险组(n=42) | 低营养不良风险组(n=181) | 中高营养不良风险组(n=156) | 检验统计量值 | P值 | |
|---|---|---|---|---|---|---|
| 年龄〔M(P25,P75),岁〕 | 83.0(77.6,89.3) | 86.0(81.0,90.0)d | 89.0(85.0,92.0)de | 24.004c | <0.001 | |
| 年龄分布 | ||||||
| 60~80〔n(%),岁〕 | 17.0(40.5) | 44(24.3)d | 18(11.5)de | 19.316a | <0.001 | |
| 81~100〔n(%),岁〕 | 25.0(59.5) | 137(75.7)d | 138(88.5)de | |||
| 性别(男/女) | 19/23 | 123/58d | 124/32de | 19.372a | <0.001 | |
| BMI( | 25.54±3.07 | 24.37±3.79d | 23.11±4.02de | 6.799b | 0.001 | |
| 卧床〔n(%)〕 | 4.0(9.5) | 16.0(8.8) | 49.0(31.4)de | 31.054a | <0.001 | |
| 住院时间〔M(P25,P75),d〕 | 10.0(7.0,12.0) | 11.0(8.0,14.0)d | 14.0(10.3,19.0)de | 38.843c | <0.001 | |
| NYHA分级〔n(%)〕 | 37.051a | <0.001 | ||||
| Ⅱ级 | 32.0(76.2) | 113.0(62.4)d | 54.0(34.6)de | — | — | |
| Ⅲ级 | 90.0(21.4) | 54.0(29.8)d | 80.0(51.3)de | — | — | |
| Ⅳ级 | 1.0(2.4) | 14.0(7.7)d | 22.0(14.1)de | — | — | |
| 合并疾病〔n(%)〕 | ||||||
| 高血压 | 37.0(88.1) | 154.0(85.1) | 134.0(85.9) | 0.258a | 0.879 | |
| 糖尿病 | 25.0(59.5) | 114.0(63.0) | 97.0(62.2) | 0.175a | 0.916 | |
| 心房颤动 | 12.0(28.6) | 61.0(33.7) | 64.0(41.0) | 3.122a | 0.210 | |
| 慢性肾脏病 | 5.0(11.9) | 63.0(34.8)d | 68.0(43.6)d | 14.614a | 0.001 | |
| 陈旧性心肌梗死 | 9.0(21.4) | 38.0(21.0) | 50.0(32.1)de | 5.809a | 0.055 | |
| 慢性阻塞性肺疾病 | 10.0(23.8) | 39.0(21.5) | 43.0(27.6) | 1.656a | 0.437 | |
| 肿瘤 | 1.0(2.4) | 28.0(15.5)d | 31.0(19.9)d | 7.631a | 0.022 | |
| 药物应用〔n(%)〕 | ||||||
| 他汀类药物 | 31.0(73.8) | 133.0(73.5) | 99.0(63.5) | 4.394a | 0.111 | |
| 生化指标 | ||||||
| 血红蛋白〔M(P25,P75),g/L〕 | 132.0(122.8,140.3) | 124.0(111.0,133.0)d | 109.0(97.0,127.0)de | 49.562c | <0.001 | |
| 淋巴细胞〔M(P25,P75),×109/L〕 | 1.98(1.66,2.24) | 1.43(1.11,1.80)d | 1.23(0.94,1.49)de | 58.625c | <0.001 | |
| 血钾( | 4.03±0.29 | 4.05±0.39 | 4.09±0.44 | 0.599b | 0.550 | |
| 血钠〔M(P25,P75),mmol/L〕 | 140.00(138.00,141.07) | 140.00(138.00,142.00) | 139.00(136.32,141.00)e | 6.204c | 0.045 | |
| 空腹血糖〔M(P25,P75),mmol/L〕 | 5.44(4.85,7.02) | 5.72(4.88,6.80) | 5.42(4.69,6.67) | 2.904c | 0.234 | |
| 尿素氮〔M(P25,P75),mmol/L〕 | 5.45(4.35,7.13) | 6.60(5.20,8.45)d | 7.20(5.30,9.75)de | 15.658c | <0.001 | |
| 肌酐〔M(P25,P75),μmol/L〕 | 76.25(65.80,90.85) | 85.90(70.95,180.00)d | 93.85(72.85,127.13)de | 13.514c | 0.001 | |
| 总蛋白( | 68.12±5.11 | 63.34±6.97d | 60.17±7.14de | 24.346b | <0.001 | |
| 血清白蛋白( | 38.70±2.66 | 36.83±3.28d | 31.39±3.24de | 155.901b | <0.001 | |
| 三酰甘油〔M(P25,P75),mmol/L〕 | 1.46(1.10,2.01) | 1.09(0.82,1.40)d | 0.75(0.59,0.75)de | 60.147c | <0.001 | |
| 总胆固醇〔M(P25,P75),mmol/L〕 | 4.74(3.97,5.36) | 3.58(3.12,4.43)d | 3.21(2.69,3.66)de | 82.847c | <0.001 | |
| 低密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 2.94(2.34,3.51) | 1.94(1.54,2.48)d | 1.67(1.34,2.03)de | 74.269c | <0.001 | |
| 高密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 1.05(0.95,1.49) | 1.06(0..87,1.34) | 1.05(0.76,1.23) | 5.274c | 0.072 | |
| 糖化血红蛋白〔M(P25,P75),%〕 | 6.40(5.90,7.90) | 6.30(5.85,7.25) | 6.10(5.70,7.00) | 4.158c | 0.125 | |
| BNP〔M(P25,P75),mmol/L〕 | 132.00(60.00,227.00) | 157.00(75.00,295.00)d | 311.50(130.25,580.50)de | 38.160c | <0.001 | |
| 左心室射血分数〔M(P25,P75),%〕 | 61.00(58.00,65.00) | 62.00(57.50,64.00) | 60.00(55.00,65.00) | 4.528c | 0.104 | |
| GNRI( | 106.19±6.55 | 101.06±9.26d | 89.48±10.66de | 65.538b | <0.001 | |
| PNI( | 48.78±3.83 | 44.43±3.89d | 37.80±4.14de | 179.977b | <0.001 | |
| 1年内因HF再入院〔n(%)〕 | 9.00(21.4) | 32.00(17.7) | 56.00(35.9)de | 15.033a | 0.001 | |
| 1年内HF全因死亡〔n(%)〕 | 0 | 14.00(7.7)d | 62.00(39.7)de | 65.394a | <0.001 | |
Table 1 Demographic and clinical indicators among older patients with HFpEF and coronary heart diseases according to the CONUT score
| 项目 | 无营养不良风险组(n=42) | 低营养不良风险组(n=181) | 中高营养不良风险组(n=156) | 检验统计量值 | P值 | |
|---|---|---|---|---|---|---|
| 年龄〔M(P25,P75),岁〕 | 83.0(77.6,89.3) | 86.0(81.0,90.0)d | 89.0(85.0,92.0)de | 24.004c | <0.001 | |
| 年龄分布 | ||||||
| 60~80〔n(%),岁〕 | 17.0(40.5) | 44(24.3)d | 18(11.5)de | 19.316a | <0.001 | |
| 81~100〔n(%),岁〕 | 25.0(59.5) | 137(75.7)d | 138(88.5)de | |||
| 性别(男/女) | 19/23 | 123/58d | 124/32de | 19.372a | <0.001 | |
| BMI( | 25.54±3.07 | 24.37±3.79d | 23.11±4.02de | 6.799b | 0.001 | |
| 卧床〔n(%)〕 | 4.0(9.5) | 16.0(8.8) | 49.0(31.4)de | 31.054a | <0.001 | |
| 住院时间〔M(P25,P75),d〕 | 10.0(7.0,12.0) | 11.0(8.0,14.0)d | 14.0(10.3,19.0)de | 38.843c | <0.001 | |
| NYHA分级〔n(%)〕 | 37.051a | <0.001 | ||||
| Ⅱ级 | 32.0(76.2) | 113.0(62.4)d | 54.0(34.6)de | — | — | |
| Ⅲ级 | 90.0(21.4) | 54.0(29.8)d | 80.0(51.3)de | — | — | |
| Ⅳ级 | 1.0(2.4) | 14.0(7.7)d | 22.0(14.1)de | — | — | |
| 合并疾病〔n(%)〕 | ||||||
| 高血压 | 37.0(88.1) | 154.0(85.1) | 134.0(85.9) | 0.258a | 0.879 | |
| 糖尿病 | 25.0(59.5) | 114.0(63.0) | 97.0(62.2) | 0.175a | 0.916 | |
| 心房颤动 | 12.0(28.6) | 61.0(33.7) | 64.0(41.0) | 3.122a | 0.210 | |
| 慢性肾脏病 | 5.0(11.9) | 63.0(34.8)d | 68.0(43.6)d | 14.614a | 0.001 | |
| 陈旧性心肌梗死 | 9.0(21.4) | 38.0(21.0) | 50.0(32.1)de | 5.809a | 0.055 | |
| 慢性阻塞性肺疾病 | 10.0(23.8) | 39.0(21.5) | 43.0(27.6) | 1.656a | 0.437 | |
| 肿瘤 | 1.0(2.4) | 28.0(15.5)d | 31.0(19.9)d | 7.631a | 0.022 | |
| 药物应用〔n(%)〕 | ||||||
| 他汀类药物 | 31.0(73.8) | 133.0(73.5) | 99.0(63.5) | 4.394a | 0.111 | |
| 生化指标 | ||||||
| 血红蛋白〔M(P25,P75),g/L〕 | 132.0(122.8,140.3) | 124.0(111.0,133.0)d | 109.0(97.0,127.0)de | 49.562c | <0.001 | |
| 淋巴细胞〔M(P25,P75),×109/L〕 | 1.98(1.66,2.24) | 1.43(1.11,1.80)d | 1.23(0.94,1.49)de | 58.625c | <0.001 | |
| 血钾( | 4.03±0.29 | 4.05±0.39 | 4.09±0.44 | 0.599b | 0.550 | |
| 血钠〔M(P25,P75),mmol/L〕 | 140.00(138.00,141.07) | 140.00(138.00,142.00) | 139.00(136.32,141.00)e | 6.204c | 0.045 | |
| 空腹血糖〔M(P25,P75),mmol/L〕 | 5.44(4.85,7.02) | 5.72(4.88,6.80) | 5.42(4.69,6.67) | 2.904c | 0.234 | |
| 尿素氮〔M(P25,P75),mmol/L〕 | 5.45(4.35,7.13) | 6.60(5.20,8.45)d | 7.20(5.30,9.75)de | 15.658c | <0.001 | |
| 肌酐〔M(P25,P75),μmol/L〕 | 76.25(65.80,90.85) | 85.90(70.95,180.00)d | 93.85(72.85,127.13)de | 13.514c | 0.001 | |
| 总蛋白( | 68.12±5.11 | 63.34±6.97d | 60.17±7.14de | 24.346b | <0.001 | |
| 血清白蛋白( | 38.70±2.66 | 36.83±3.28d | 31.39±3.24de | 155.901b | <0.001 | |
| 三酰甘油〔M(P25,P75),mmol/L〕 | 1.46(1.10,2.01) | 1.09(0.82,1.40)d | 0.75(0.59,0.75)de | 60.147c | <0.001 | |
| 总胆固醇〔M(P25,P75),mmol/L〕 | 4.74(3.97,5.36) | 3.58(3.12,4.43)d | 3.21(2.69,3.66)de | 82.847c | <0.001 | |
| 低密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 2.94(2.34,3.51) | 1.94(1.54,2.48)d | 1.67(1.34,2.03)de | 74.269c | <0.001 | |
| 高密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 1.05(0.95,1.49) | 1.06(0..87,1.34) | 1.05(0.76,1.23) | 5.274c | 0.072 | |
| 糖化血红蛋白〔M(P25,P75),%〕 | 6.40(5.90,7.90) | 6.30(5.85,7.25) | 6.10(5.70,7.00) | 4.158c | 0.125 | |
| BNP〔M(P25,P75),mmol/L〕 | 132.00(60.00,227.00) | 157.00(75.00,295.00)d | 311.50(130.25,580.50)de | 38.160c | <0.001 | |
| 左心室射血分数〔M(P25,P75),%〕 | 61.00(58.00,65.00) | 62.00(57.50,64.00) | 60.00(55.00,65.00) | 4.528c | 0.104 | |
| GNRI( | 106.19±6.55 | 101.06±9.26d | 89.48±10.66de | 65.538b | <0.001 | |
| PNI( | 48.78±3.83 | 44.43±3.89d | 37.80±4.14de | 179.977b | <0.001 | |
| 1年内因HF再入院〔n(%)〕 | 9.00(21.4) | 32.00(17.7) | 56.00(35.9)de | 15.033a | 0.001 | |
| 1年内HF全因死亡〔n(%)〕 | 0 | 14.00(7.7)d | 62.00(39.7)de | 65.394a | <0.001 | |
| 变量 | 单因素分析 | 多因素分析 | |||||
|---|---|---|---|---|---|---|---|
| OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
| 年龄 | 1.035(1.001,1.069) | 0.034 | 0.042 | — | — | — | |
| 卧床 | 0.532(0.305,0.930) | -0.630 | 0.027 | — | — | — | |
| 住院时间 | 1.029(1.001,1.056) | 0.028 | 0.038 | — | — | — | |
| NYHA | — | — | — | ||||
| Ⅱ级 | 1 | — | — | — | |||
| Ⅲ级 | 2.021(1.213,3.339) | 0.699 | 0.007 | — | — | — | |
| Ⅳ级 | 3.849(1.835,8.070) | 1.348 | <0.001 | — | — | — | |
| 合并慢性肾脏病 | 0.618(0.386,0.990) | -0.481 | 0.045 | — | — | — | |
| 血红蛋白 | 0.979(0.966,0.992) | -0.021 | 0.001 | — | — | — | |
| 尿素氮 | 1.079(1.025,1.137) | 0.076 | 0.004 | — | — | — | |
| 肌酐 | 1.008(1.004,1.013) | 0.008 | <0.001 | 1.009(1.003,1.015) | 0.009 | 0.004 | |
| 血糖 | 0.884(0.772,1.013) | -0.123 | 0.076 | — | — | — | |
| 血清白蛋白 | 0.899(0.849,0.951) | -0.107 | <0.001 | — | — | — | |
| 三酰甘油 | 0.649(0.428,0.985) | -0.432 | 0.042 | — | — | — | |
| 糖化血红蛋白 | 0.866(0.702,1.068) | -0.144 | 0.179 | — | — | — | |
| BNP | 1.001(1.000,1.001) | 0.001 | 0.006 | 1.001(1.000,1.002) | 0.001 | 0.018 | |
| 左心室射血分数 | 0.933(0.888,0.930) | -0.069 | 0.006 | — | — | — | |
| GNRI | 0.972(0.949,0.995) | -0.029 | 0.016 | — | — | — | |
| CONUT评分 | 1.236(1.121,1.363) | 0.212 | <0.001 | — | — | — | |
| PNI | 0.927(0.887,0.969) | -0.076 | 0.001 | — | — | — | |
Table 2 Univariable and multivariable analyses of factors predicting HF-related readmission in elderly patients with HFpEF and coronary heart disease within 1 year after discharge
| 变量 | 单因素分析 | 多因素分析 | |||||
|---|---|---|---|---|---|---|---|
| OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
| 年龄 | 1.035(1.001,1.069) | 0.034 | 0.042 | — | — | — | |
| 卧床 | 0.532(0.305,0.930) | -0.630 | 0.027 | — | — | — | |
| 住院时间 | 1.029(1.001,1.056) | 0.028 | 0.038 | — | — | — | |
| NYHA | — | — | — | ||||
| Ⅱ级 | 1 | — | — | — | |||
| Ⅲ级 | 2.021(1.213,3.339) | 0.699 | 0.007 | — | — | — | |
| Ⅳ级 | 3.849(1.835,8.070) | 1.348 | <0.001 | — | — | — | |
| 合并慢性肾脏病 | 0.618(0.386,0.990) | -0.481 | 0.045 | — | — | — | |
| 血红蛋白 | 0.979(0.966,0.992) | -0.021 | 0.001 | — | — | — | |
| 尿素氮 | 1.079(1.025,1.137) | 0.076 | 0.004 | — | — | — | |
| 肌酐 | 1.008(1.004,1.013) | 0.008 | <0.001 | 1.009(1.003,1.015) | 0.009 | 0.004 | |
| 血糖 | 0.884(0.772,1.013) | -0.123 | 0.076 | — | — | — | |
| 血清白蛋白 | 0.899(0.849,0.951) | -0.107 | <0.001 | — | — | — | |
| 三酰甘油 | 0.649(0.428,0.985) | -0.432 | 0.042 | — | — | — | |
| 糖化血红蛋白 | 0.866(0.702,1.068) | -0.144 | 0.179 | — | — | — | |
| BNP | 1.001(1.000,1.001) | 0.001 | 0.006 | 1.001(1.000,1.002) | 0.001 | 0.018 | |
| 左心室射血分数 | 0.933(0.888,0.930) | -0.069 | 0.006 | — | — | — | |
| GNRI | 0.972(0.949,0.995) | -0.029 | 0.016 | — | — | — | |
| CONUT评分 | 1.236(1.121,1.363) | 0.212 | <0.001 | — | — | — | |
| PNI | 0.927(0.887,0.969) | -0.076 | 0.001 | — | — | — | |
| 变量 | 单因素分析 | 多因素分析 | |||||
|---|---|---|---|---|---|---|---|
| OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
| 年龄 | 1.061(1.020,1.103) | 0.059 | 0.003 | — | — | — | |
| BMI | 0.911(0.839,0.990) | -0.093 | 0.027 | — | — | — | |
| 卧床 | 0.246(0.139,0.436) | -1.4 | <0.001 | — | — | — | |
| 住院时间 | 1.109(1.064,1.115) | 0.103 | <0.001 | — | — | — | |
| NYHA | — | — | — | ||||
| Ⅱ级 | 1 | — | — | — | |||
| Ⅲ级 | 2.769(1.564,4.904) | 1.019 | <0.001 | — | — | — | |
| Ⅳ级 | 5.217(2.375,11.463) | 1.652 | <0.001 | — | — | — | |
| 血红蛋白 | 0.966(0.952,0.980) | -0.035 | <0.001 | — | — | — | |
| 淋巴细胞 | 0.495(0.299,0.821) | -0.703 | 0.006 | — | — | — | |
| 血钠 | 0.934(0.872,1.002) | -0.068 | 0.055 | — | — | — | |
| 总蛋白 | 0.956(0.922,0.992) | -0.044 | 0.017 | — | — | — | |
| 血清白蛋白 | 0.805(0.750,0.864) | -0.217 | <0.001 | — | — | — | |
| 三酰甘油 | 0.663(0.420,1.048) | -0.411 | 0.079 | — | — | — | |
| BNP | 1.001(1.001,1.002) | 0.001 | <0.001 | 1.001(1.000,1.002) | 0.002 | 0.012 | |
| 左心室射血分数 | 0.928(0.880,0.979) | -0.075 | 0.007 | — | — | — | |
| GNRI | 0.939(0.912,0.967) | -0.063 | <0.001 | — | — | — | |
| CONUT评分 | 1.644(1.392,1.943) | 0.497 | <0.001 | 1.567(1.302,1.885) | 0.449 | <0.001 | |
| PNI | 0.084(0.796,0.890) | -0.173 | <0.001 | — | — | — | |
Table 3 Univariable and multivariable analyses of factors predicting all-cause mortality in elderly patients with HFpEF and coronary heart diseases within 1 year after discharge
| 变量 | 单因素分析 | 多因素分析 | |||||
|---|---|---|---|---|---|---|---|
| OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
| 年龄 | 1.061(1.020,1.103) | 0.059 | 0.003 | — | — | — | |
| BMI | 0.911(0.839,0.990) | -0.093 | 0.027 | — | — | — | |
| 卧床 | 0.246(0.139,0.436) | -1.4 | <0.001 | — | — | — | |
| 住院时间 | 1.109(1.064,1.115) | 0.103 | <0.001 | — | — | — | |
| NYHA | — | — | — | ||||
| Ⅱ级 | 1 | — | — | — | |||
| Ⅲ级 | 2.769(1.564,4.904) | 1.019 | <0.001 | — | — | — | |
| Ⅳ级 | 5.217(2.375,11.463) | 1.652 | <0.001 | — | — | — | |
| 血红蛋白 | 0.966(0.952,0.980) | -0.035 | <0.001 | — | — | — | |
| 淋巴细胞 | 0.495(0.299,0.821) | -0.703 | 0.006 | — | — | — | |
| 血钠 | 0.934(0.872,1.002) | -0.068 | 0.055 | — | — | — | |
| 总蛋白 | 0.956(0.922,0.992) | -0.044 | 0.017 | — | — | — | |
| 血清白蛋白 | 0.805(0.750,0.864) | -0.217 | <0.001 | — | — | — | |
| 三酰甘油 | 0.663(0.420,1.048) | -0.411 | 0.079 | — | — | — | |
| BNP | 1.001(1.001,1.002) | 0.001 | <0.001 | 1.001(1.000,1.002) | 0.002 | 0.012 | |
| 左心室射血分数 | 0.928(0.880,0.979) | -0.075 | 0.007 | — | — | — | |
| GNRI | 0.939(0.912,0.967) | -0.063 | <0.001 | — | — | — | |
| CONUT评分 | 1.644(1.392,1.943) | 0.497 | <0.001 | 1.567(1.302,1.885) | 0.449 | <0.001 | |
| PNI | 0.084(0.796,0.890) | -0.173 | <0.001 | — | — | — | |
Figure 1 ROC curve analysis of the CONUT score,GNRI and PNI in predicting readmission for HF in elderly patients with HFpEF and coronary heart diseases within 1 year after discharge
Figure 2 ROC curve analysis of the CONUT score,GNRI and PNI in predicting all-cause mortality in elderly patients with HFpEF and coronary heart diseases within 1 year after discharge
| [1] |
World population prospects 2019[EB/OL].(2019-12-31)[2020-12-31].
|
| [2] |
中国发展研究基金会. 中国老年人营养与健康报告[M]. 北京:中国发展出版社,2016.
|
| [3] |
|
| [4] |
王丹,郝瑞瑞,姜春燕. 老年住院患者营养状况对预后影响的临床观察[J]. 临床和实验医学杂志,2016,15(16):1571-1574. DOI:10.3969/J.ISSN.1671-4695.2016.16.007.
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
Editorial:Major changes made by Criteria Committee of the New York Heart Association[J]. Circulation,1974,49(3):390. DOI:10.1161/01.cir.49.3.390.
|
| [9] |
|
| [10] |
中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):760-789. DOI:10.3760/cma.j.issn.0253-3758.2018.10.004.
|
| [11] |
中国超重/肥胖医学营养治疗专家共识编写委员会. 中国超重/肥胖医学营养治疗专家共识(2016年版)[J]. 糖尿病临床,2016,10(10):451-455. DOI:10.3969/j.issn.1672-7851.2016.10.003.
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [1] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [2] | BAO Ruolin, LU Chao, FENG Xin, YE Chunmei, LAI Fenhua, NI Zuowei, YANG Dongbo, ZHENG Yongtao. Predictive Model for Breakthrough Influenza Cases in the Elderly Population: a Nested Case-control Study [J]. Chinese General Practice, 2026, 29(19): 2671-2677. |
| [3] | LIU Yang, ZHOU Guoping, LI Xiaoshi, LI Ping, ZHANG Xin. Impact of Acute Respiratory Distress Syndrome Etiology on the Prognostic Value of Driving Pressure: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(19): 2638-2647. |
| [4] | LUAN Xiaoqing, SUN Jingjing, LI Xiaoling, WANG Manxia. Research Progress on Potential Biomarkers of Neuromyelitis Optica Spectrum Disorder [J]. Chinese General Practice, 2026, 29(17): 2418-2424. |
| [5] | LI Shilong, WANG He, ZHOU Xiaoyu, FU Lei, ZHAO Zhuo, HUA Chengjun, SI Chunying. Advances in the Study of Cardiac Macrophages in Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2026, 29(15): 2084-2091. |
| [6] | XIONG Siyu, LU Bing, JIANG Wenhong, YU Tingting. Study on the Relationship between Fructose-1, 6-Bisphosphate Aldolase A Expression before and after Targeted Drug Resistance in Lung Adenocarcinoma and Patient Prognosis [J]. Chinese General Practice, 2026, 29(14): 1883-1889. |
| [7] | ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da. Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province [J]. Chinese General Practice, 2026, 29(13): 1759-1765. |
| [8] | SUN Xia, SHEN Wen, TANG Xiang, ZHONG Wei, WANG Kailin, DAI Zhiyin, ZHANG Chaopu, YUAN Wei, YUAN Guoyue. Analysis of Clinical Characteristics in Dilated Cardiomyopathy Patients with Different Weight Statuses and the Influence of Weight Management on the Prognosis [J]. Chinese General Practice, 2026, 29(11): 1448-1455. |
| [9] | XIA Ning, SHI Lan, DING Wanbao, ZHANG Jie, LONG Yi, DAI Hui, ZHANG Can, DAI Hailong. Clinical Characteristics and Prognosis of Patients with Amyloidosis [J]. Chinese General Practice, 2026, 29(09): 1161-1167. |
| [10] | YANG Juan, LIU Shan, LI Fei, MENG Haodong, QIAO Hui, XIE Yongxin. Dynamic Monitoring and Analysis of Influencing Factors of Health Shocks in Rural Middle Aged and Elderly People in Ningxia: Empirical Research Based on 14 Years and Four Periods of Follow-up Data before and after Poverty Alleviation [J]. Chinese General Practice, 2026, 29(07): 914-921. |
| [11] | WANG Lina, LEI Jingshu, LI Kuibao, WANG Ruiying, LI Xinmiao, WANG Fangfang, GUO Xiaorong, NIU Ruihao, ZHAO Wei, ZHOU Fangfang, ZHAO Jingjing, LEE CHONGYOU. Review on Inflammatory Response in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(06): 790-801. |
| [12] | LEI Chunxin, ZHANG Xiya, ZHANG Yan, CHEN Jiaqi, LIU Zihan, LUO Jing, TAO Qingwen. Clinical Characteristics and Influencing Factors of Primary Sjögren's Disease with Dryness and Blood-stasis Syndrome [J]. Chinese General Practice, 2026, 29(06): 718-725. |
| [13] | WANG Xue, YANG Chengming, WANG Ziyun, ZHOU Zhong. Analysis on Prognosis and Influencing Factors in Patients with Post-tuberculosis Bronchiectasis [J]. Chinese General Practice, 2026, 29(05): 606-611. |
| [14] | FU Jiyi, ZHENG Boyue, WU Jiafei, WANG Jun, LI Hui. Efficacy and Safety of a Combined Regimen of Histone Deacetylase Inhibitors Venetoclax and Azacitidine in Adult T-cell Acute Lymphoblastic Leukemia [J]. Chinese General Practice, 2026, 29(04): 483-489. |
| [15] | WANG Yiheng, XU Xiaoming, XIA Yunlong, XIA Linying, HAN Xue, GUO Yongzhen, LIU Quanchi, YAN Wenjun. Progress in Pharmacotherapy of Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2026, 29(03): 403-408. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||